By

Sara Dagen

UF Study Finds 1 in 16 Women Take Harmful Drugs During Pregnancy

In a review of more than 3 million pregnancies, University of Florida researchers found 1 in 16 women were exposed to harmful teratogenic drugs — medications that can cause pregnancy loss, birth defects, and other health problems for the unborn child.

UF and IBM Team Up To Solve Society’s Biggest Challenges

The University of Florida announced this week a new collaboration with tech giant IBM to launch a comprehensive skills program designed to extend UF’s vision to be an international leader in artificial intelligence, data science, fintech, and other related technologies that can help solve society’s biggest challenges.

TearClear Announces Initiation of TC-002 Latanoprost Ophthalmic Solution Phase 3 Trial

TearClear has announced the TC-002 phase 3 trial has been successfully initiated. TearClear’s phase 3 trial (CLEAR Study) is a prospective, double-masked, randomized, multicenter, active-controlled, parallel-group, 3-month study assessing the safety and ocular hypotensive efficacy of TC-002 ophthalmic solution (TearClear Preservative-Free Latanoprost Ophthalmic Solution 0.005%) compared to marketed Latanoprost ophthalmic solution 0.005%.